The expression of survivin mRNA and the survivin protein in colorectal cancer was recently investigated using molecular biology methods, including reverse transcription-polymerase chain reaction (RT-PCR) [32,33], Western blot [33] and ELISA [34] assays, as well as immunohistochemical staining [35]. The gene discussed is BIRC5; the disease is colorectal cancer.